Dismenore Primer

01Pathophysiology

Primary dysmenorrhea occurs exclusively in ovulatory cycles. This is a critical teaching point: the condition does not present before menarche or during anovulatory cycles. After ovulation, the corpus luteum produces progesterone, which stimulates the endometrium to accumulate arachidonic acid within the phospholipid membrane of endometrial cells. When progesterone levels drop at the end of the luteal phase (in the absence of pregnancy), the endometrium breaks down, releasing phospholipase A2. This enzyme liberates arachidonic acid, which is then converted by cyclooxygenase (COX) enzymes into prostaglandins, primarily $PG{F}_{2\alpha }PGF\_\{2\backslash alpha\}$ and $PG{E}_{2}PGE\_2$.

$PG{F}_{2\alpha }PGF\_\{2\backslash alpha\}$ is the dominant mediator. It causes myometrial hypercontractility, leading to increased intrauterine pressure that can exceed 150 to 200 mmHg (far above normal resting tone of roughly 10 mmHg). These intense, sustained contractions compress the uterine blood vessels, producing ischemia of the myometrium. This ischemia is the direct source of the cramping pain, and the mechanism is analogous to angina pectoris: demand exceeds supply because the contracting muscle outstrips its own perfusion.

The prostaglandins also enter the systemic circulation, which explains the systemic symptoms. $PG{E}_{2}PGE\_2$ acts on the thermoregulatory center and GI smooth muscle, accounting for the nausea, vomiting, diarrhea, and headache that frequently accompany the pain. Elevated vasopressin levels have also been documented in patients with primary dysmenorrhea, further intensifying uterine contractions and contributing to ischemia.

Because the pathophysiology depends on progesterone-primed endometrium, primary dysmenorrhea typically begins 6 to 12 months after menarche, once ovulatory cycles become established. Pain that begins at menarche itself should raise suspicion for an obstructive anatomic anomaly (e.g., imperforate hymen or transverse vaginal septum), which would be secondary dysmenorrhea.

02Classification and Clinical Manifestation

Timing characteristics are the single most useful clinical discriminator:

03Diagnostic Workup

Primary dysmenorrhea is fundamentally a clinical diagnosis. The exam question will present a young woman with cyclical menstrual pain, a normal pelvic exam, and no red flags. The correct answer is to treat empirically with NSAIDs rather than ordering extensive imaging.

The best initial test is a thorough history and pelvic examination. When the pain pattern is classic (onset with menstrual flow, duration < 72 hours, crampy quality, no intermenstrual pain, no dyspareunia) and the pelvic exam is normal, no further workup is needed.

Ultrasound becomes appropriate when the history deviates from the classic pattern: pain that is progressive over months to years, pain outside of menstruation, new onset of dysmenorrhea in a woman over 25, or abnormal findings on pelvic exam (adnexal mass, fixed retroverted uterus, uterosacral nodularity). These features suggest secondary dysmenorrhea, most commonly from endometriosis or adenomyosis.

If the patient fails to respond to a trial of NSAIDs plus hormonal contraceptives (typically after 3 to 6 months of adequate therapy), this is a strong indication to pursue further evaluation with pelvic ultrasound and potentially laparoscopy. The failure to respond to standard therapy is itself a diagnostic clue pointing away from primary dysmenorrhea.

A trial of empiric therapy effectively doubles as a diagnostic tool: primary dysmenorrhea responds well, secondary causes often do not.

04Management and Treatment

The first move for any patient presenting with classic primary dysmenorrhea is an NSAID. NSAIDs work by inhibiting cyclooxygenase, thereby blocking the synthesis of the prostaglandins that drive the pathology. The choice of NSAID is less important than the timing: the drug must be started at or just before the onset of menstrual bleeding to preempt prostaglandin accumulation. Starting the medication after pain has already peaked is significantly less effective, and this timing point is frequently tested.

Among NSAIDs, mefenamic acid has a theoretical advantage because it both inhibits prostaglandin synthesis and blocks prostaglandin receptor activity, but in practice, ibuprofen and naproxen are used more commonly and are considered equivalent. Aspirin is less effective than other NSAIDs and is not recommended as first-choice therapy.

If NSAIDs alone are insufficient, or if the patient also desires contraception, combined oral contraceptive pills are added or substituted. COCs reduce dysmenorrhea by suppressing ovulation (thereby preventing the progesterone-driven prostaglandin cascade) and by producing a thinner endometrial lining with less tissue to slough and less substrate for prostaglandin production. Continuous or extended-cycle regimens that reduce the number of withdrawal bleeds per year can provide additional benefit.

For patients who have contraindications to estrogen (history of venous thromboembolism, migraine with aura, smokers over 35), progestin-only methods are appropriate alternatives. The levonorgestrel IUD is particularly effective because it induces endometrial atrophy and often reduces menstrual flow.

Non-pharmacologic adjuncts should be offered routinely. Continuous low-level topical heat (approximately 39 degrees Celsius) applied to the lower abdomen has been shown in randomized trials to provide analgesia comparable to ibuprofen. Regular exercise reduces dysmenorrhea severity through endorphin-mediated analgesia and improved pelvic blood flow.

Acetaminophen is notably less effective than NSAIDs for dysmenorrhea because it has minimal anti-prostaglandin activity at the peripheral level. On an exam, if acetaminophen is listed alongside an NSAID as a treatment option, the NSAID is the correct answer.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on primary dysmenorrhea questions is by ordering unnecessary imaging or labs when the clinical picture is straightforward. The vignette will describe a 16-year-old with two years of crampy pain starting with her period, a normal pelvic exam, and no red flags. The "next best step" is empiric NSAID therapy, not a pelvic ultrasound. Ordering imaging in this setting is the classic wrong answer because it represents over-testing a clinical diagnosis.

The second major trap involves confusing primary with secondary dysmenorrhea. The exam will embed distinguishing details to see if you recognize them. Pain that is progressive over years, pain that occurs between periods, new-onset dysmenorrhea after age 25, or abnormal pelvic exam findings all point to secondary causes and should trigger further workup. If the vignette describes a 32-year-old with worsening dysmenorrhea, dyspareunia, and difficulty conceiving, the answer is endometriosis, not primary dysmenorrhea.

A third testing theme is NSAID timing. Students who recognize the correct drug class but select "start ibuprofen when pain becomes severe" will miss the point. The tested concept is that NSAIDs must be initiated at or before the onset of menstrual flow for maximum benefit, because the goal is to prevent prostaglandin accumulation rather than to counteract prostaglandins already in circulation.

Finally, watch for the question that asks about a patient who fails both NSAIDs and COCs after an adequate trial. The tested competency here is recognizing when a clinical diagnosis should be revisited. The next best step in a treatment-refractory patient is to reconsider the diagnosis and investigate for secondary causes (pelvic ultrasound, then laparoscopy for suspected endometriosis), not to escalate to opioids or stronger analgesics.

The core competency being tested across all primary dysmenorrhea questions is the ability to make a confident clinical diagnosis based on a typical history and normal exam, initiate appropriate empiric therapy with correct timing, and know when the clinical picture no longer fits and further investigation is warranted.